Neoplastic clonal selection with HER2 amplification in otherwise HER2 negative tumors as well as HER2 silenced tumor areas in cases with homogeneous HER2 amplification have been proposed as mechanisms leading to HER2 expression heterogeneity [36]. Here, ERBB2 is linked to neoplasm.